NCT02596399View on ClinicalTrials.gov

A Study to Investigate Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 29, 2015

Primary Completion Date

May 30, 2016

Study Completion Date

May 30, 2016

Conditions
Healthy Volunteer
Interventions
DRUG

DSTA4637S

Participants will receive DSTA4637S intravenously on Day 1.

DRUG

Placebo

Participants will receive placebo matched to DSTA4637S intravenously on Day 1.

Trial Locations (1)

66219

PRA International Clinical Pharmacology Center (EDS US Clinic), Lenexa

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY

NCT02596399 - A Study to Investigate Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Healthy Volunteers | Biotech Hunter | Biotech Hunter